Commercial Supply Solifenacin Succinate Related Intermediates:
Solifenacin Succinate CAS: 242478-38-2
(R)-(-)-3-Quinuclidinol CAS: 25333-42-0
(S)-(+)-3-Quinuclidinol CAS: 34583-34-1
3-Quinuclidinone Hydrochloride CAS: 1193-65-3
1-Phenyl-1,2,3,4-Tetrahydro-Isoquinoline CAS: 22990-19-8
(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS: 118864-75-8
| Chemical Name |
(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline |
| Synonyms |
Solifenacin Succinate Intermediate F; (S)-1,2,3,4-Tetrahydro-1-Phenylisoquinoline |
| CAS Number |
118864-75-8 |
| CAT Number |
RF-CC120 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C15H15N |
| Molecular Weight |
209.29 |
| Density |
1.065 |
| Solubility |
Soluble in Methanol |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
Pale Yellow to White Crystalline Powder |
| Identification by IR |
Corresponds to the Reference Spectrum |
| Identification by HPLC |
Retention Time Complies |
| Melting Point |
80.0～92.0℃ |
| Specific Rotation [α]D20 |
+45.0°～+50.0° (C=2.8, CCl4) |
| Moisture (K.F) |
≤0.50% |
| Loss on Drying |
≤0.50% |
| Residue on Ignition |
≤0.30% |
| Purity |
≥99.5% |
| Benzoylphenethylamine |
≤0.30% |
| Isoqulnoline, 3,4-dihydro-1-phenyl |
≤0.30% |
| Any Other Single Impurity |
≤0.30% |
| Total Impurities |
≤0.50% |
| Chiral Purity |
≥99.5% |
| Enantiomer |
≤0.50% (HPLC) |
| Test Standard |
Enterprise Standard |
| Usage |
Intermediate of Solifenacin Succinate (CAS: 242478-38-2) |
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline (CAS: 118864-75-8) with high quality. It is an intermediate typically in the synthesis of Solifenacin Succinate (CAS: 242478-38-2). Solifenacin Succinate is a competitive M3 muscarinic receptor antagonist used in treatment of overactive bladder (pollakiuria) and reduces micturition, urgency, and incontinence in Europe. Solifenacin is a competitive cholinergic receptor antagonist. Solifenacin succinate is a urinary antispasmodic of the antimuscarinic class.